Germline-Activating RRAS2 Mutations Cause Noonan Syndrome
- 1 June 2019
- journal article
- research article
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 104 (6) , 1233-1240
Abstract
No abstract availableKeywords
Funding Information
- US National Institutes of Health (MH106826)
- AMED (JP18ek0109241, JP18ek0109278, JP18ek0109280, JP18dm0107090, JP18ek0109301, JP18ek0109348, JP18kk020501)
- Japan Society for the Promotion of Science (JSPS) Kakenhi (JP16K15522, JP17H01539, JP17H06994, JP15KK0293)
This publication has 32 references indexed in Scilit:
- Expression of H-RASV12 in a zebrafish model of Costello syndrome causes cellular senescence in adult proliferating cellsDisease Models & Mechanisms, 2009
- The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disordersHuman Mutation, 2008
- Shp2 Knockdown and Noonan/LEOPARD Mutant Shp2–Induced Gastrulation DefectsPLOS Genetics, 2007
- Noonan syndromeOrphanet Journal of Rare Diseases, 2007
- Germline Mutations in Genes Within the MAPK Pathway Cause Cardio-facio-cutaneous SyndromeScience, 2006
- Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndromeNature Genetics, 2006
- Germline KRAS mutations cause Noonan syndromeNature Genetics, 2006
- Germline mutations in HRAS proto-oncogene cause Costello syndromeNature Genetics, 2005
- TC21 mediates transformation and cell survival via activation of phosphatidylinositol 3-kinase/Akt and NF-κB signaling pathwayOncogene, 2002
- Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndromeNature Genetics, 2001